Eric Warren
2023
In 2023, Eric Warren earned a total compensation of $1.1M as Chief Commercial Officer at Esperion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $241,259 |
|---|---|
| Option Awards | $269,200 |
| Salary | $462,500 |
| Stock Awards | $89,646 |
| Other | $15,100 |
| Total | $1,077,705 |
Warren received $462.5K in salary, accounting for 43% of the total pay in 2023.
Warren also received $241.3K in non-equity incentive plan, $269.2K in option awards, $89.6K in stock awards and $15.1K in other compensation.
Rankings
In 2023, Eric Warren's compensation ranked 1,125th out of 2,983 executives tracked by ExecPay. In other words, Warren earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,125 out of 2,983 | 62nd |
Division Manufacturing | 669 out of 1,637 | 59th |
Major group Chemicals And Allied Products | 452 out of 906 | 50th |
Industry group Drugs | 441 out of 869 | 49th |
Industry Pharmaceutical Preparations | 302 out of 627 | 52nd |
Source: SEC filing on April 11, 2024.
Warren's colleagues
We found two more compensation records of executives who worked with Eric Warren at Esperion Therapeutics in 2023.